Lag 3 inhibitors are shaping up as the next big thing. trials have shown that in combination with PD1 inhibitors they improve efficacy alot. That combination efficacy looks like being the new benchmark. Should we get ahead of the curve and have a pd1/lag3/fto inhibitor vs pd1/lag3 trial in the mix? BP is looking at LAG 3 as the next big thing. If you have trials with LAG 3 in the mix it will help zantrene catch the attention of BP and just seems like a good idea. thoughts? somebody float this with Dr T please.
Lag 3 inhibitors are shaping up as the next big thing. trials...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.095(7.22%) |
Mkt cap ! $234.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.41 | $1.32 | $249.8K | 182.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2826 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.37 |
Change
0.095 ( 6.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.41 | $1.32 | 16145 | ||
| Last updated 15.53pm 10/05/2024 ? | |||||
| RAC (ASX) Chart |